Blueprint Medicines (BPMC) PT Lowered to $97 at Wedbush
Tweet
Share
E-mailGet Alerts BPMC Hot Sheet
Price: $129.46 --0%
Rating Summary:
11 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 23
Rating Summary:
11 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 23
Join SI Premium – FREE
Wedbush analyst David Nierengarten lowered the price target on Blueprint Medicines (NASDAQ: BPMC) to $97.00 (from $100.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Revolution (RVMD) PT Raised to $275 at Needham
- LightPath Technologies (LPTH) PT Lowered to $15.50 at Canaccord
- Mizuho Downgrades Sempra Energy (SRE) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
